Mitsui Chemicals, Inc. (MITUF)
USD 21.45
(0.0%)
USD 21.45
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 161.33 Billion | 762.04 Million | 760.57 Million | 1.57 Billion | 1.31 Billion | 989.22 Million |
| Net Income | 49.99 Billion | 624.25 Million | 903.56 Million | 523.73 Million | 314.66 Million | 687.67 Million |
| Depreciation & Amortization | 95.24 Billion | 693.08 Million | 691.88 Million | 693.4 Million | 704.08 Million | 447.25 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.33 Billion | -514.3 Million | -884.37 Million | 227.5 Million | 171.86 Million | -181.64 Million |
| Other non-cash items | 221.47 Billion | -40.99 Million | 49.5 Million | 132.94 Million | 126.89 Million | 35.93 Million |
| Investing Cash Flow | -123.92 Billion | -917.75 Million | -1.76 Billion | -676.51 Million | -1.01 Billion | -577.31 Million |
| Investments in PPE | -153.99 Billion | -1.03 Billion | -954.71 Million | -693.04 Million | -924.19 Million | -505.43 Million |
| Acquisitions | 33.97 Billion | -189.04 Million | -358.53 Million | 15.1 Million | 10.55 Million | 46.2 Million |
| Investment purchases | -2.09 Billion | -41.33 Million | -503.87 Million | -48.29 Million | -57.7 Million | -216.39 Million |
| Sales/Maturities of investments | 1.05 Billion | 347.31 Million | 24.14 Million | 47.6 Million | 3.31 Million | 85.23 Million |
| Other Investing Activities | -2.87 Billion | 2.98 Million | 30.94 Million | 2.11 Million | -42.69 Million | 13.08 Million |
| Financing Cash Flow | -26.02 Billion | 136.47 Million | 89.22 Billion | -649.37 Million | -58.95 Million | -130.9 Million |
| Debt repayment | -13.66 Billion | -522.17 Million | -19.29 Billion | -337.96 Million | -338.05 Million | -188.73 Million |
| Dividends payments | -24.71 Billion | -24.16 Billion | -20.52 Billion | -19.34 Billion | -19.5 Billion | -18.87 Billion |
| Common Stock Repurchased | -49 Million | -75.44 Million | -10.03 Billion | -6.25 Million | -86.97 Million | -90.64 Million |
| Common Stock Issuance | 3 Million | 37.63 Thousand | 6 Million | 27.14 Thousand | 185.26 Thousand | 45.17 Thousand |
| Other Financing Activities | -5.97 Billion | 915.9 Million | 100.49 Billion | -130.08 Million | 546.59 Million | 318.98 Million |
| Accounts receivables | -19.22 Billion | 161.14 Million | -517.06 Million | -64.37 Million | 324.45 Million | -29.4 Million |
| Accounts payables | 10.4 Billion | -82.94 Million | 328.33 Million | -49.04 Million | -292.26 Million | 11.74 Million |
| Inventory | -730 Million | -517.24 Million | -670.19 Million | 247.6 Million | 117.39 Million | -240.58 Million |
| Other working capital | 4.21 Billion | -75.27 Million | -25.45 Million | 93.32 Million | 22.27 Million | 76.6 Million |
| Cash at beginning of period | 186.31 Billion | 1.48 Billion | 1.77 Billion | 1.52 Billion | 992.35 Million | 741.21 Million |
| Cash at end of period | 210.29 Billion | 1.4 Billion | 1.48 Billion | 1.77 Billion | 1.52 Billion | 992.35 Million |
| Capital Expenditure | -153.99 Billion | -1.03 Billion | -954.71 Million | -693.04 Million | -924.19 Million | -505.43 Million |
| Effect of forex changes on cash | 12.59 Billion | 7.71 Billion | 8.59 Billion | 3.6 Billion | -1.67 Billion | -92 Million |
| Net cash flow / Change in cash | 23.98 Billion | -85.8 Million | -285.47 Million | 249.19 Million | 532.08 Million | 251.14 Million |
| Free Cash Flow | 7.34 Billion | -275.63 Million | -194.13 Million | 884.54 Million | 393.32 Million | 483.78 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 12.73 Billion | 49.99 Billion | 117.45 Million | 74.25 Million | 66.44 Million | 624.25 Million |
| Depreciation & Amortization | 25.09 Billion | 95.24 Billion | 169.19 Million | 155.03 Million | 160.12 Million | 693.08 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.14 Billion | -5.33 Billion | -102.03 Million | 377.37 Million | -319.96 Million | -514.3 Million |
| Other non-cash items | 74.78 Billion | 221.47 Billion | 22.06 Million | 45.93 Million | 12.13 Million | -40.99 Million |
| Investing Cash Flow | -54.17 Billion | -123.92 Billion | -243.24 Million | -303.75 Million | 68.98 Million | -917.75 Million |
| Investments in PPE | -53.06 Billion | -153.99 Billion | -269.96 Million | -250.22 Million | -176.23 Million | -1.03 Billion |
| Acquisitions | -318 Million | 33.97 Billion | 33.51 Million | 195.27 Million | 2.67 Million | -189.04 Million |
| Investment purchases | -1.2 Billion | -2.09 Billion | -4.39 Million | -836.5 Thousand | -1.01 Million | -41.33 Million |
| Sales/Maturities of investments | 771 Million | 1.05 Billion | 637.83 Thousand | -243.44 Million | 253.36 Million | 347.31 Million |
| Other Investing Activities | -358 Million | -2.87 Billion | -3.03 Million | -4.52 Million | -9.8 Million | 2.98 Million |
| Financing Cash Flow | -2.31 Billion | -26.02 Billion | 21.47 Billion | -22.19 Billion | -22.97 Billion | 136.47 Million |
| Debt repayment | -1.27 Billion | -13.66 Billion | -13.19 Billion | -30.22 Billion | -21.16 Billion | -522.17 Million |
| Dividends payments | - | -24.71 Billion | -13.31 Billion | -1 Million | -11.4 Billion | -24.16 Billion |
| Common Stock Repurchased | -15 Million | -49 Million | -15 Million | -10 Million | -9 Million | -75.44 Million |
| Common Stock Issuance | - | 3 Million | 2 Million | 1 Million | - | 37.63 Thousand |
| Other Financing Activities | -1.53 Billion | -5.97 Billion | 21.6 Billion | -52.41 Billion | 9.6 Billion | 915.9 Million |
| Accounts receivables | -27.87 Billion | -19.22 Billion | -127.39 Million | 37.32 Million | 145.84 Million | 161.14 Million |
| Accounts payables | 2.54 Billion | 10.4 Billion | 140.27 Million | 102.26 Million | -188.58 Million | -82.94 Million |
| Inventory | 10.42 Billion | -730 Million | -89.18 Million | 83.39 Million | -76.43 Million | -517.24 Million |
| Other working capital | 8.93 Billion | 4.21 Billion | -25.72 Million | 154.39 Million | -200.8 Million | -75.27 Million |
| Cash at beginning of period | 214.59 Billion | 186.31 Billion | 1.35 Billion | 1.17 Billion | 1.4 Billion | 1.48 Billion |
| Cash at end of period | 210.29 Billion | 210.29 Billion | 1.52 Billion | 1.35 Billion | 1.17 Billion | 1.4 Billion |
| Capital Expenditure | -53.06 Billion | -153.99 Billion | -269.96 Million | -250.22 Million | -176.23 Million | -1.03 Billion |
| Effect of forex changes on cash | 5.8 Billion | 12.59 Billion | -4.28 Billion | 3.59 Billion | 7.48 Billion | 7.71 Billion |
| Net cash flow / Change in cash | -4.3 Billion | 23.98 Billion | 165.29 Million | 184.38 Million | -231.19 Million | -85.8 Million |
| Free Cash Flow | -6.68 Billion | 7.34 Billion | -63.27 Million | 402.36 Million | -257.49 Million | -275.63 Million |
JBCHEPHARM
RFG
EQFN
300133
ROX
FNR